Something on your mind? Erica & Jules would love to hear from you!
In this episode Erica recaps some of her favorite celiac disease research (and more) from Digestive Disease Week 2023. Learn about the advances in a cure for celiac disease with upcoming clinical trials for KAN-101, DONQ52 and more. Included is an interview with Dr. Jason Tye-Din about clinical trials for celiac disease research, new drugs, and the possibility to test for celiac disease without a gluten challenge (in the future).
RESOURCES
Celiac Disease Foundation 2023 DDW Wrap-up
Beyond Celiac 2023 DDW Research
Celiac disease drugs show progress from Beyond Celiac
Study: OAT AVENIN TRIGGERS ACUTE SYMPTOMS AND IMMUNE ACTIVATION IN SOME PEOPLE WITH CELIAC DISEASE BUT ADVERSE IMMUNE AND CLINICAL EFFECTS ARE ABSENT WITH EXTENDED INGESTION
Study: KAN-101: PHARMACODYNAMIC DEMONSTRATION OF IMMUNOLOGICAL TOLERANCE INDUCED BY KAN-101, A NOVEL LIVER-TARGETED THERAPY FOR CELIAC DISEASE, PERSISTS FOLLOWING DRUG CLEARANCE
Study: DONQ52: A BISPECIFIC ANTIBODY TARGETING HLA-DQ2.5-GLUTEN PEPTIDES POTENTLY BLOCKS GLUTEN-SPECIFIC T CELLS INDUCED BY GLUTEN INGESTION IN PATIENTS WITH CELIAC DISEASE
Eating disorders and IBS study
Dating with Celiac Disease from Dr. Jessica Lebovitz on Celiac and the Beast's Instagram
Contact/Follow Jules & Erica
Thanks for listening! Be sure to subscribe!
**some links may be affiliate links; purchasing through these links will not cost you more, but will help to fund the podcast you ❤️